
Jean-Michel Halfon
Independent Director
Qualifications: With his years of experience in senior management at leading pharmaceutical companies, particularly his experience with emerging markets, Mr. Halfon provides expertise in international pharmaceutical operations and marketing.
Mr. Halfon joined the Board of Directors in 2014.
From 2008 to 2010, Mr. Halfon served as President and General Manager of Emerging Markets at Pfizer Inc., after serving in various senior management positions since 1989. From 1987 to 1989, Mr. Halfon served as Director of Marketing in France for Merck & Co., Inc.
Mr. Halfon received a B.S. from Ecole Centrale des Arts et Manufactures and an M.B.A. from Institut Supérieur des Affaires.

Dr. Sol J. Barer
Chairman of the Board Independent Director

Kåre Schultz
Director and President and Chief Executive Officer

Rosemary A. Crane
Independent Director

Amir Elstein
Independent Director

Janet S. Vergis
Independent Director

Roberto A. Mignone
Independent Director

Dr. Perry D. Nisen
Independent Director

Nechemia (Chemi) J. Peres
Independent Director

Dr. Tal Zaks
Independent Director

Prof. Ronit Satchi-Fainaro
Independent Director

Gerald M. Lieberman
Independent Director
At Teva, we strive to deliver quality medicines to patients around the world with integrity and ethical business practices. What we do is important, but how we do it is just as important. Learn more:
Copyright © 2022 Teva Pharmaceutical Industries Ltd.